दीपफार्मा > कंपनी इतिहास > Pharmaceuticals > कंपनी इतिहास का दीपफार्मा - बीएसई: 507722, NSE: DEEPHARMA


बीएसई: 507722  |  NSE: DEEPHARMA  |  ISIN:  |  Pharmaceuticals

कंपनी इतिहास - दीपफार्मा
The origin of the Company can be traced back to 1978 when the
 partnership business under the name and style of M/s. Dee-Pharma
 started manufacturing pharmaceutical and drug formulations.
 On 23rd April, 1984 a company in the name and style Dee-Pharma Pvt. 
 Ltd. was incorporated.  On 1st April, 1985 the Company was taken as a
 partner in the firm M/s. Dee-Pharma.  On 2nd December, 1985 Dee-Pharma
 pvt. Ltd. was converted into a public limited company.  The
 firm was dissolved on 31st December, 1985 and entire business of the
 firm including licenses, patents, trade marks etc. was taken over by
 Dee-Pharma Limited as a going concern and the partners were paid the
 amount outstanding in their capital accounts.
 In 1986, the Company entered the Capital Market with a public issue
 of 6,50,000 equity shares of Rs.10/- each for cash at par aggregating
 Rs.  65.00 lacs.  The issue was over subscribed and the Company
 retained 25% over subscription to augment its long term working
 capital requirements.
 In the year 1989-90 the Company shifted its entire manufacturing
 activities  from B-142, OKhla Phase-1, New Delhi to A-3/2, Industrial
 Area, Sikandrabad, Distt Bulandshahr, U.P.
 In the year 1991, DPL expanded its operations by setting up a new
 plant for the manufacture of Injectables at its factory in
 Sikandrabad.  The total capital outlay for this expansion programme
 was Rs. 245.87 lacs which was financed by a rights issue of 24,58,700
 equity shares of Rs. 10/- each for cash at par agg. RL 245.87 lacs. 
 In addition Rs. 35.12 lacs was also retained constituting 15% of the
 oversubscription with the permission of the Controller of Capital
 Issues, by issue of 3,51,240 equity shares of Rs. 10/- each to meet
 out the long term working capital
 requirements of the Company.
स्रोत: रेलीगरे टेचनोवा

न्यूज़ फ़्लैश

  • MARKET CUES : FIIs ने कैश में `585 Cr की खरीदारी की
  • MARKET CUES : DIIs ने कैश में `890 Cr की बिकवाली की
  • MARKET CUES : FIIs ने F&O में `483 Cr की बिकवाली की
  • MARKET CUES : इंडेक्स फ्यूचर्स में `172 Cr की बिकवाली की
  • MARKET CUES : इंडेक्स ऑप्शंस में `151 Cr की खरीदारी की
  • MARKET CUES : स्टॉक फ्यूचर्स में `388 Cr की बिकवाली की
  • CS ON BHEL : Outperform रेटिंग, लक्ष्य `88/Sh
  • CS ON CADILA HEALTH : Neutral रेटिंग, लक्ष्य `251/Sh
  • CS ON PIDILITE IND : Underperform रेटिंग, लक्ष्य `1245/Sh
  • MACQUARIE ON BHEL : Neutral रेटिंग, लक्ष्य घटाकर `58/Sh

अभी देखें




(August 06, 2018)

AT (Rs)






Super Combo

Powerful mix of both trader and investor packs with timely expert advice.


Designed especially for traders looking to tap the profit opportunities of volatile markets.


For all investors looking to unearth stocks that are poised to move.